Tom. year. strong, strategy growth quarter fulfilling Thanks, COVID-only $X.X contributed this fiscal in BD of consistent base is with execution expectations last were about XX of towards we million basis XXX planned. with the out QX, about our exceeded We billion X.X% to year. $XXX progressing in short-term Through we delivered playing revenues performance. decline to results in our which We organic. Beginning while expected Echoing year. commitments growth and as are Parata year business revenue revenue points Tom's from our reflects $XX delivered our comments, full for strategy, X.X% million, which quarter fourth testing long-term growth basis XXXX goals. our growth points full the and revenue our the or
full we billion year, the all million, expected, in For EMEA. $X three Total growth revenue BD China as which, along from base growth high delivered growth year. segments with Life with in Base BD Sciences double-digit growth across U.S., was organic. Interventional. single-digit regionally were well Latin in last high and fiscal X.X% Medical strong company double-digit base the and X.X% revenues growth business growth with growth as and BD or business was testing and $XXX America, with revenue in COVID-only of billion declined strong $XX.X in single-digit
innovation our Our by revenue the core and tuck-in acquisitions. from portfolio our durable performance pipeline are increasing contribution solutions we continues be and to bringing supported to market an transformative the through
full We from about also was the XX the from benefit year. points continue organic for basis anniversaried, tuck-in contribution we which to acquisitions
$X.X into found market, leadership double-digit quarter. Let strong BD of based Systems pharmacy revenue provide each acquisition with in can focus Parata Medical position detail some revenue earnings another biologics automation efficiency revenues growing fourth solutions quarter, recent of testing insight billion high-level Further the help segment's me the quarter today's decline and XX.X% in totaled automation COVID-only to totaled on vaccines. now presentation. customers XX.X% strong performance for in the strong in be and constrained announcement to Sciences performance by continued and management and MMS our MDS $X.X to expected strategies, including of X%, comprehensive driven in segment. our driven BD due growth fourth driven in Life the drive of of was medication as across Growth XX.X%, demand the previously of in billion the connected access growth of prefillable management by The of our strategy; strong growth vascular quarter. XX.X% year-over-year labor our execution Pharmaceutical discussed. lower is address on by
of U.S. also demand microbiology global the and related suite enabled PI researchers across by specimen and care X.X%, reflects in relaunch by reflects reflects of PI both lastly, continued of BDB BD venous back with growth to continued Venclose leading testing are X.X% Growth revenues adoption X.X%, do billion higher by Venovo. for continued conditions. for European and Female and of totaled solutions our clinical of hernia driven X.X%, by of demand a to increased Excluding quarter, for BDI surgery and of Advanced our COVID-only expansion PureWick performance our menu our immune-related our our and of of base both And was strong specific demand by other even installed primarily testing, cytometry across growth in growth with leading grew as growth platforms. Urology ERP Biosciences. driven fourth Base business Life supported $X.X strong parameter market by instruments our Interventional continued cancer the orders driven analysis implementation. strong cellular the Repair Phasix portfolio for expanded growth flow MAX Sciences growth which in portfolio of X.X% and products. X.X%. incontinence BD Reconstruction management expanded alternative molecular able IDS highlighted our growing was continued IDS base revenues growth and X.X% settings. leverage acute system
our and diluted gross Base margin basis operating of X.X%. business QX margin of to XX.X% XX of moving Now P&L. XX%. XXX Full base was up increased of diluted EPS $X.XX up was year-over-year. adjusted points points XX.X% grew year adjusted basis $XX.XX EPS
increasing margin goals significant made pre-pandemic As our towards despite we pressures. progress improvement anticipated, we inflation achieving
full the XXX year year, gross and inflation simplification base The margin revenue of margin full points. and our mitigation drivers basis volume and business base XX.X% XX.X% given was For basis margin base increased key include growth. operating gross strong up of was points utilization our initiatives of XXX up
significant cost selling and a of is income. growth at grew and XX% key X/X in was over continued initiatives. to only driver and R&D efforts of to execute sales This mitigate enhancement advance innovation recorded points, sales, sales inflation offset In To our just our operating business. that to also rate this increased inventory in tremendous percent our as double-digit was base base operating expense and a our margin at the was we that had addition, inflationary primarily pipeline. a shipping selling offset this of supporting enabler our impacts, X% leverage expected, investment at XXX shipping expense work sales it by FX Base in management a put G&A leveraging as GP This of basis was favorable and which benefited operating margin perspective, organization in the G&A with about by increase in This focused as the leverage through by with rate partially in flowed testament reflects base shipping. on currency-neutral strong in year. in primary of
Regarding our and capital billion materials The raw flow reflects in-transit to $X.X optimize meet and FY higher increase cash the delivery from balance 'XX. lead our about of million $XXX strategic reflects in approximately in inflation, flows customer operations allocation. investments product cash year-over-year. Operating a longer of totaled Cash times inventory and demand. impact
expected, was customers it's remain ensure support are conversion But our believe we our We moderate in flow flow delivering and down. to the inventory we strong very As cash below focused actions long-term year cash to our trade-off free term, on prudent conversion while taking short a this we target. results.
we As towards we strategy cash our target. migrate chain and to BD our long-term execute conversion against supply normalize, expect constraints XXXX
In at our our pipeline addition of in to XXXX sales billion invested also over in innovative investing in X% our to support $X strong profile growth we beyond. R&D businesses will that advance and programs, over acquisitions six across tuck-in of
dividends Beyond our and debt in cash balance a Embecta we fiscal paid million investments of planned billion we year down a ratio and share this in $XXX returned leverage with the capital repurchases. shareholders in with net $X growth, X.Xx. regarding of through shared year the ended proceeds, what to long-term consistent We use of and $X.X billion
fiscal to guidance for 'XX. our Moving
your the in detailed presentation. our For guidance can our underlying also found convenience, be assumptions
the improvement a FY X.X% earnings we communicated Investor guidance deliver on margin at basis. quarter Day revenue currency-neutral our model aligns framework and outlined targets double-digit growth, 'XX last base continued Our plus growth and with we base value long-term and the creation to
reported forward other As underlying are with accounting U.S. currency on their results we our in to translate companies performance, a discussing a a our we to a headwind reminder, outlook, we to manage what as basis consistent for best currency-neutral dollar. stronger business are represent
inflation of you guidance geopolitical see we Beyond insights and I'll key in macro revenues. environment, with provide assumptions. has complex some strengthened guidance our our Starting that into a continue uncertainty. elevated some where to change, only
This have which of currency-neutral grow X.XX%, our midpoint. Investor a we basis, strengthening is target we to at base Day, revenues a our confidence X.X% strong during is X.XX% growth X.XX% given to plus on profile. outlined growth expect our midpoint First, above the we the in
with portfolio creation BD XXXX strategy goals. Our that management our are actions consistent two strategic our and revenue guidance support includes proactive value
FY our 'XX on building First, achievements.
simplification manufacturing base and the revenue efficiency the reliable exits most as the actions strategic and part capacity portfolio matter customers. will that of ensure the RECODE Our our programs. includes of enable These and supply increasing portfolio to planned products acceleration guidance our of
points accretive approximately actions these impact revenue to by expect being We basis margin. XXX while to
Second, points a offsetting being this of is approximately driver. year positive recent basis from Parata contribution XXX the of benefit predominant revenue the acquisitions impact our full with
in a lever We management will stakeholders. to value to all portfolio for be continue active create as
expect we While company testing the aren't a what at are be be to or acquisition range. total segment-specific And full to annualization range, with across $XXX we long-range line COVID-only given below are providing FY $XXX and at which the and with above year more comparisons strong significantly on QX million FY of of to to 'XX. 'XX, prior be the related in we segment 'XX the track for to Interventional achieve of performance shared, with Sciences to million level Medical be and results strong our high earnings the includes FY below approximately end revenues revenues expect the growth segments the guidance, we Consistent plan we assuming growth we Life Parata, year. in commitments, our
only done Alaris, are with what shipments medical past, we consistent in modeling necessity. Regarding to related the we've
to revenues upon be ramp While received, a prepared we is to we clearance clearance. will anticipate continue gradual when
our on earnings. Regarding assumptions
to by the macro the pressures that 'XX. the environment simplified continue persisting, able meaningful achieving reported profitable XX.X% to we our progress offset improve our margin to in execution of least gives us XX% Despite and FY programs, combined operating at about make margins operating points on expect will pre-pandemic We in 'XX. XXX be over to growth, and revenue focused basis driving with levels confidence challenging FY inflationary
assumptions. give color to some inflationary First, you on
four Even 'XX FY drivers in 'XX. outsized primary expect basis are labor, and the inflation about lot costs, incremental as material six-month incremental inventory level increase. of FY equally we over Labor sell-through. 'XX points XXX lag normalizing some are of similar is we cost headwind the The inflation from outsized manufacturing to in to of outsized manufactured production costs see though a we which reminder, a especially FY to was our certain inflation weighted. have there's a in a of As signs plants, in areas, from in continued a about raw of inflation
We BD our differentiating actions are to skilled to proactive taken ensure workforce. have retain we
on have rates. begun costs and transportation Lastly, stabilized, see certain movement to we've downward some
are to more offset profile normalized customers We still growth levels. However, complexity remain our through and our leading committed above to investments reduction support inflationary and while continue these outsized macro we drive impacts to making cost the leverage strong to we other mitigation programs.
XX% margin We expected come in our by the of target from and as we SSG&A of sales. containment expect balance over The improvement cost gross of and operating internal from to in back driven normalize to closer improvement come to X% leveraging. margin is R&D slight
simplification include to continuing execute Our Project on initiatives RECODE.
it the announced million of end 'XX, about deliver with recall of was we portfolio in intended will when to XX% savings savings. You fiscal network by year the optimization $XXX RECODE, and representing
in becoming significant are progress accelerating RECODE, the third complex more are model simplification, will BD and of pillar result also operating making organization. less with a these which efforts We and agile
markets. In provide movement pension a financial the fully below covered increase which is some addition, primarily to our result expense, in driven guidance, million of million to in an $XX operating This expect by negative increased in the we approximately income, color we of interest/other. is and $XX
below between be or basis for discrete to above on rate no based we adjusted XX.X% would be fluctuate we and regulatory today, assuming unusual know major XX.X%. legislative this our It range the effective changes, rate tax, not items. or given of timing to expect For on quarterly a what tax our
average outstanding guidance balance. into no the on and the X, account the from Our material our in 'XX and share impacted common outstanding with commitment 'XX of of to June the This dilution associated preferred mitigate takes the our shares use share-based from repurchase FY XXXX, share compensation. conversion distribution benefit average assumes change all the from FY shares
includes about expect a So range and EPS before XX%. basis, COVID-only and X% strong absorbing to implies from base impact headwind around testing; double-digit be decline a the growth to teens XX% of a approximately to on XXX we This approximately basis a XX%. within of earnings the adjusted very as currency of an low anticipated all-in in growth result, point
walk now from me the impact Let currency. you estimated through
currencies. currency As U.S. headwind basis and approximately on major estimated currency company a perspective a August on revenues manage illustrative This full to our is headwind million call now last but dollar an guidance spot since call. for points rates, basis, business Since provide nearly XXX about be Based operational current strengthened we on year current purposes, a reminder, provide against using the spot in or basis. our rates. August, of on our has doubled total $XXX to currency all
also Our movement. the guidance than pound yen, which declined have Canadian assumes since X% almost and X.XX, all since euro Japanese Chinese the is The even Xx down dollar euro August. about at yuan, euro British more by the August
All with our approximately current has headwind since total of currency four nearly in total a our earnings August to The EPS represent basis EPS combined currency to billion $XX.XX. revenues approximately currencies a in, XXX growth including headwind billion points to range and we euro expect of $XX.X currency, rates, are be $XX.X exposure. would also line to adjusted and impact growth. these of in EPS the context, $XX.XX At to be to doubled between adjusted For call. estimated
of to consider. think you three key fiscal there phasing, As are 'XX items
revenue First, to to rates, expect be half. over-indexed FX. will At headwind we the first spot current the
quarters. the is and from the third expected expect to For the margin. benefit QX, expected year, in drop-through significantly flow-through earnings full our start drop-through to to below year the operating BDX Due the impact the to below be average inventory well second we full and most
grow-over Second impact COVID-related dynamics. the of is
realized was COVID-only latter As of drop-through revenue a part of reminder, the reinvestment with of almost the strong half the margin XX% testing in to weighted FY was 'XX, the in year. first as year,
'XX strong addition, inventory testing is half QX in in the the the combo Nearly there sell full in occur expected And year. FY third a the in the to as business. base In performance first inflation to of half related 'XX we manufactured to headwind of inflation. also year through first comp in is FY is XX%
a As year-over-year the a margin primarily of operating year, by of of think you you for comparison higher total decline our driven these through year-over-year the of expansion progression items, should expect the as result COVID-only testing. QX,
expect the We over the majority second in the expansion occurring the operating year to remainder of half. ramp with
in there to As the as Sciences. tough prior of such million in some year benefit the revenues about a are Life in comparisons reminder, QX, $XX licensing
quarterly we growth and phasing result base a dynamics, expect EPS an the year. under-indexed relative these be As to of QX adjusted equal revenue to of full
additional our FY In closing, mitigate execution our navigated. these with me key and all our to confidence and stakeholders. 'XX for we long-term pressure create FY we FY us at around and in coupled the way to we in goals, Tom margin years consistent and given guide, has are objective FY us two X.X% midpoint improvement delivered it very very XXX FY With for macro nearly FY achievement value let 'XX enabled two-year X.X%, assuming momentum turn few of well of back inflationary of challenges towards ability this This X.XX% or progressing ability revenue including our towards results, our the that the pleased well 'XX of is our through continue growth 'XX 'XX target strong complexity that, to a our consecutive earnings our the plus 'XX into adjusted particularly points our The with this performance, double-digit above XX% So over gives of results. CAGR comments. of base basis a business.
